<DOC>
<DOCNO>1060310_business_story_5950009.utf8</DOCNO>
<TEXT>


The Telegraph - Calcutta : Business

 Ranbaxy, Zenotech in pact 

 OUR CORRESPONDENT

 New Delhi, March 9: Ranbaxy Laboratories today entered into a strategic alliance with Zenotech Laboratories Ltd (Zenotech), India to market drugs and injections used for the treatment of cancer. According to the pact, Ranbaxy will sell Zenotechs oncology injections under its own brand in the key markets of Latin America, Russia and other CIS countries.

 Ranbaxy is also exploring options to expand the collaboration to other markets. Zenotech will develop and manufacture these drugs at its dedicated facilities in India. 

 The alliance facilitates Ranbaxys entry into this therapeutic segment in these key markets. It will continue to strengthen its product portfolio and provide novel products for the benefit of patients, said Peter Burema, president of Ranbaxys operations in Europe, Africa, CIS and Latin America.




</TEXT>
</DOC>